SCHEMBL16127

SCHEMBL16127

O=S(=O)(C1=CC=CCC1=S)N1CCN[C@](CN2C3COCC2C(O)C3)(c2ncc(C(O)(C(F)(F)F)C(F)(F)F)cn2)C1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034 0.95 GCK (0.39) GCK
SCHEMBL17376 0.85 GCK (0.43) GCK
SCHEMBL21749 0.85 RORC (0.39) GCK
SCHEMBL16486 0.81 GCK (0.30) GCK
SCHEMBL16348 0.80
SCHEMBL16053 0.78 GCK (0.51) GCK
SCHEMBL12079764 0.78 GCK (0.51) GCK
SCHEMBL30016 0.78 GCK (0.51) GCK
SCHEMBL17957 0.78
SCHEMBL18067 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed